SPOTLIGHT -
Dr. Ryan J. Sullivan on Frontline Immunotherapy Sequencing in Melanoma
Cancer Network spoke with Ryan J. Sullivan, MD, of Massachusetts General Hospital, about the debate between immunotherapy sequencing vs targeted therapy for melanoma.
What to Do When Anti–PD-1 Therapy Fails in Patients With Melanoma
This review summarizes the current available treatment strategies for patients with advanced melanoma when PD-1–directed therapy is not enough.
Entinostat Plus Pembrolizumab Shows Promise in Previously Treated Melanoma
Cancer Network spoke with Ryan J. Sullivan, MD, about the efficacy and safety of entinostat plus pembrolizumab in patients previously treated with immunotherapy.
Dissecting Adjuvant Therapy Options in Melanoma
Cancer Network speaks with Dr. Ryan J. Sullivan about adjuvant therapies in development for melanoma patients.
ASCO 2018 Highlights: Melanoma Studies
Medical oncologist Ryan J. Sullivan shared some interesting melanoma-related presentations from the 2018 ASCO Annual Meeting.
Optimal Treatment Selection for Patients With Metastatic Melanoma
In early 2015, determining the optimal treatment regimen for a patient with metastatic melanoma remains challenging.
